Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| OF THE INVENTION The present invention relates to alterations in the KVLQT1, HERG, SCN5A, KCNE1 ... |
|
Method for forming image |
| OF THE INVENTION In accordance with the present invention there is provided a method for ... |
|
WF11243 substance |
| We claim: 1. An isolated compound having formula (I): ##STR4## or a salt thereof. 2. A method for ... |
|
Electrophoretic method for the isolation and separation of microorganisms and cell populations |
| It is an object of the invention to provide a novel electrophoretic method for the separation of ... |
|
Human antithrombin III |
| The present invention is directed to the means and methods of producting human antithrombin III via ... |
|
Cryptophycins |
| OF THE INVENTION The present invention provides novel cryptophycin compounds having the following ... |
|
Method for recovery of refined .alpha.-galactosidase |
| OF THE INVENTION The methods heretofore suggested for the refinement of .alpha.-galactosidase ... |
|
Antimicrobial composition containing Type II endoglycosidase and antimicrobial agent |
| The invention provides antimicrobial methods utilizing Type II endoglycosidases such as endo-.beta.-... |
|
Wound healing composition of IGF-I and TGF-.beta. |
| We claim: 1. A method for healing an external wound of a mammal comprising applying to said wound a ... |
|
|
Labelled oligonucleotides synthesized on solid-supports
| Details |
Inventors: Lee, Linda G.; Mullah, Khairuzzaman B.; Rosenblum, Barnett B.;
Assignee: PE Corporation (NY) (Foster City, CA)
Primary Examiner: Riley; Jezia
Assistant Examiner:
Attorney, Agent or Firm: Andrus; Alex
Methods and compositions to label oligonucleotides and analogs directly on a solid-support having the structure ##STR1## where S is a solid-support, A is a cleavable linker, X is a moiety with three or more attachment sites, L is a label, Y is a nucleophile, i.e. O, NH, NR or S, and P.sub.1 is an acid cleavable protecting group are provided. The labelled solid-support is reacted in a cyclical fashion to synthesize a labelled oligonucleotide on a solid-support in the 5' to 3' direction, having the structure: ##STR2## Labelled oligonucleotides are also synthesized by reacting: (i) a label reagent bearing functionality consisting of carboxylic acid, sulfonic acid, phosphonic acid, or phosphoric acid, (ii) an oligonucleotide on solid support with nucleophilic functionality, and (iii) a coupling reagent, whereby an ester, amide, thioester, sulfonamide, sulfonate, phosphonate, phosphoramidate, phosphorothioate, or phosphate bond is formed. The labelling reaction may be conducted at label sites including the 5' terminus, the 3' terminus, a nucleobase, an internucleotide linkage, a sugar, amino, sulfide, hydroxyl, and carboxyl. |
|
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Reference will now be made in detail to the preferred embodiments of the invention, examples of which are illustrated in the accompanying drawings. While the invention will be described in conjunction with the preferred embodiments, it will be understood that they are not intended to limit the invention to those embodiments. On the contrary, the invention is intended to cover alternatives, modifications, and equivalents, which may be included within the invention as defined by the appended claims. I. Definitions Unless stated otherwise, the following terms and phrases as used herein are intended to have the following meanings: The terms "nucleic acid", "polynucleotide" or "oligonucleotide" mean polymers of nucleotide monomers or analogs thereof, including double and single stranded deoxyribonucleotides, ribonucleotides, . alpha. -anomeric forms thereof, and the like. The oligonucleotide may comprise one or more DNA, RNA, and nucleic acid analog monomer units. The monomers are linked by internucleotide linkages, including phosphodiester bonds or phosphate analogs thereof, and associated counterions, e. g. , H. sup. +, NH. sub. 4. sup. +, Na. sup. +. Oligonucleotides typically range in size from a few monomeric units, e. g. 5-40, to several thousands of monomeric units. Whenever an oligonucleotide is represented by a sequence of letters, such as "ATGCCTG," it will be understood that the nucleotides are in 5' to 3' order from left to right and that "A" denotes deoxyadenosine, "C" denotes deoxycytidine, "G" denotes deoxyguanosine, and "T" denotes thymidine, unless otherwise noted. "Nucleoside" refers to a compound consisting of a purine, deazapurine, or pyrimidine nucleobase, e. g. , adenine, guanine, cytosine, uracil, thymine, deazaadenine, deazaguanosine, and the like, linked to a pentose at the 1'-position. When the nucleoside base is purine or 7-deazapurine, the pentose is attached to the nucleobase at the 9-position of the purine or deazapurine, and when the nucleobase is pyrimidine, the pentose is attached to the nucleobase at the 1-position of the pyrimidine
|
| Related patents |
|
|
Alkylene oxide modified hardwood cellulose
What is claimed is: 1. A process for the preparation of cellulose acetate comprising: mercerizing cellulosic material derived from hardwood in a caustic mercerizing ...
|
|
|
Method for polymer synthesis using arrays
What is claimed is: 1. A method of synthesis of a polymer chain in a synthesis apparatus by sequentially adding polymer units thereto, said synthesis apparatus including ...
|
|
|
Pyrrolo[2,3-d]pyrimidine derivatives, process for producing the same and pharmaceutical preparation comprising the same as active ingredient
We claim: 1. A pyrrolo[2,3-d]pyrimidine derivative represented by the general formula I: ##STR218## wherein R.sup.1 represents a hydrogen atom, or an unsubstituted or ...
|
|
|
Promoter for neuropeptide FF and use thereof for therapy and diagnostics
OF THE INVENTION We report here the cloning of the 5'-flanking region of the NPFF gene from mouse, rat and human. Totally 9.8 kb, 1.5 kb and 1.3 kb of the NPFF promoter ...
|
|
|
Transcriptional activators, and compositions and uses related thereto
OF THE INVENTION I. General Protein-encoding genes in eukaryotes are transcribed by RNA polymerase II (pol II), a multisubunit enzyme that is brought to an appropriate ...
|
|
|
Diagnostic probes for pneumocystis carini
OF THE INVENTION This invention relates to a method for diagnosing for Pneumocystis carinii by detecting the presence of a nucleic acid sequence containing the 26S rRNA ...
|
|
|
Peanut allergens and methods
OF THE INVENTION In accordance with a preferred embodiment of the present invention, a monoclonal antibody (MAb) based enzyme-linked immunosorbent assay (ELISA) and ...
|
|
|
Method for sequencing DNA using biotin-strepavidin conjugates to facilitate the purification of primer extension products
OF THE INVENTION Applicants' invention provides a simplified method for isolating primer extension products from template-directed DNA polymerase reactions. For the ...
|
|
|
Comparative genomic hybridization (CGH)
Comparative Genomic Hybridization (CGH) has also been termed Copy Ratio Reverse Cytogenetics (CRRC), competition hybridization and quantitative in situ ratio ...
|
|
|
DNA sequence-based HLA typing method
The present invention relates to a method for determining the nucleic acid sequence of one or more polymorphic genes of a subject by amplifying and direct sequencing ...
|
|
|